The University of Alabama at Birmingham (UAB) School of Education has been awarded a seven-year, $49 million grant -- its largest ever -- to serve as the hub of GEAR UP Alabama, a federally funded program to help increase the number of low-income students in Alabama's poverty-plagued Black Belt that are prepared to attend college.
It's possible that some people were infected in the gap between the onset of symptoms and the patient's isolation at Texas Health Presbyterian, according to Craig Wilson, MD, of the University of Alabama at Birmingham.
women held only 27.5 percent of jobs nationally across science and engineering fields as of 2010, according to the National Science Foundation. And it doesn't get better as you dig into the data. In engineering, women make up 12.7 percent of the workforce. In healthcare, women make up 69.7 percent of medical and health services managers, but rarely attain chief executive positions.
From the quality of medical care to access to medical care to the ability to quickly quarantine infectious diseases, there are a lot of reasons the likelihood of an Ebola outbreak here in the U.S. is so small. But if someone exhibiting Ebola like symptoms did walk into UAB Hospital, doctors say they would be ready. Emergency rooms are always busy but with Ebola fears on everyone’s mind, the ER staff at UAB is ever vigilant.
Dr. Helen Krontiras doesn’t take lightly her role in helping women live through what can be the darkest times in their lives. And with the rapid advancements in breast cancer research and treatment, the co-director of the University of Alabama at Birmingham Breast Health Center says she thinks a more personalized approach to women’s healthcare is more important than ever.
Shin J. Oh, MD, Distinguished Professor Emeritus of Neurology, University of Alabama at Birmingham, School of Medicine, stated, "I am extremely pleased to see the results from the first ever Phase 3 controlled study in this LEMS patient population, which confirmed a positive treatment effect for Firdapse. When combined with the favorable safety profile, the results indicate that the drug should become the standard of care in treating LEMS patients once approved by the FDA."